These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7325717)

  • 21. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of HIV protease inhibitor DMP 323 in rats and dogs.
    Grubb MF; Wong YN; Burcham DL; Saxton PL; Quon CY; Huang SM
    Drug Metab Dispos; 1994; 22(5):709-12. PubMed ID: 7835221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple oral dosing of ketoconazole influences pharmacokinetics of quinidine after intravenous and oral administration in beagle dogs.
    Kuroha M; Shirai Y; Shimoda M
    J Vet Pharmacol Ther; 2004 Oct; 27(5):355-9. PubMed ID: 15500574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics and metabolism of the new thromboxane A2 receptor antagonist ramatroban in animals. 1st communication: absorption, concentrations in plasma, metabolism, and excretion after single administration to rats and dogs.
    Boberg M; Ahr HJ; Beckermann B; Bühner K; Siefert HM; Steinke W; Wünsche C; Hirayama M
    Arzneimittelforschung; 1997 Aug; 47(8):928-38. PubMed ID: 9296279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of cholestyramine on the pharmacokinetics of rosiglitazone and its metabolite, desmethylrosiglitazone, after oral and intravenous dosing of rosiglitazone: impact on oral bioavailability, absorption, and metabolic disposition in rats.
    Muzeeb S; Venkatesh P; Mullangi R; Srinivas NR
    Xenobiotica; 2006 Sep; 36(9):838-56. PubMed ID: 16971347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of mebudipine, a new calcium antagonist, following single intravenous and oral administrations in rats.
    Bohlooli S; Keyhanfar F; Mahmoudian M
    Biopharm Drug Dispos; 2004 May; 25(4):187-91. PubMed ID: 15108221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of Zn DTPA for the decorporation of 238Pu-TBP injected into the lungs of hamsters.
    Stradling GN; Stather JW; Ham SE; Sumner SA; Cooper JR
    Health Phys; 1983 Jun; 44(6):645-9. PubMed ID: 6853187
    [No Abstract]   [Full Text] [Related]  

  • 28. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonlinear pharmacokinetics of cefadroxil in the rat.
    García-Carbonell MC; Granero L; Torres-Molina F; Aristorena JC; Chesa-Jiménez J; Plá-Delfina JM; Peris-Ribera JE
    Drug Metab Dispos; 1993; 21(2):215-7. PubMed ID: 8097688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.
    Chung HJ; Choi YH; Choi HD; Jang JM; Shim HJ; Yoo M; Kwon JW; Lee MG
    Eur J Pharm Sci; 2006 Mar; 27(4):363-74. PubMed ID: 16387482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetic characterization of ginsenoside Rh2, an anticancer nutrient from ginseng, in rats and dogs.
    Gu Y; Wang GJ; Sun JG; Jia YW; Wang W; Xu MJ; Lv T; Zheng YT; Sai Y
    Food Chem Toxicol; 2009 Sep; 47(9):2257-68. PubMed ID: 19524010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacokinetic study of triflusal (UR-1501)].
    Rimbau V; López R; Fernández A; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):11-2. PubMed ID: 7325699
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo metabolism and final disposition of a novel nonsteroidal androgen in rats and dogs.
    Perera MA; Yin D; Wu D; Chan KK; Miller DD; Dalton J
    Drug Metab Dispos; 2006 Oct; 34(10):1713-21. PubMed ID: 16815963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Studies using phosphoric acid ester preparations in cattle, swine and sheep, with special reference to cholinesterase activity. 2. Use of phosphoric acid ester preparations and their effect on acetylcholine esterase activity in cattle].
    Mieth K; Beier D; Losch K
    Arch Exp Veterinarmed; 1973; 27(2):371-81. PubMed ID: 4725031
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetic properties of TDP4815 after single intravenous and oral administrations to rat, rabbit, monkey, dog and in vitro drug metabolism.
    Chen Y; Cheng D; Tio C; Kagan N; Eisennagel S; Dasgupta M; Tomczuk B; Bone R; Huebert N
    Biopharm Drug Dispos; 2008 Apr; 29(3):127-38. PubMed ID: 18186144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioavailabilty and pharmacokinetics of four active alkaloids of traditional Chinese medicine Yanhuanglian in rats following intravenous and oral administration.
    Li HL; Zhang WD; Zhang C; Liu RH; Wang XW; Wang XL; Zhu JB; Chen CL
    J Pharm Biomed Anal; 2006 Jun; 41(4):1342-6. PubMed ID: 16644173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of verproside after intravenous and oral administration in rats.
    Park EJ; Lee HS; Oh SR; Lee HK; Lee HS
    Arch Pharm Res; 2009 Apr; 32(4):559-64. PubMed ID: 19407974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
    Batzias GC; Delis GA; Athanasiou LV
    Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disposition of salmeterol xinafoate in laboratory animals and humans.
    Manchee GR; Barrow A; Kulkarni S; Palmer E; Oxford J; Colthup PV; Maconochie JG; Tarbit MH
    Drug Metab Dispos; 1993; 21(6):1022-8. PubMed ID: 7905380
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.